Literature DB >> 1150037

Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives.

A E Cowen, M G Korman, A F Hofmann, P J Thomas.   

Abstract

The plasma disappearance of intravenously injected radiolabeled lithocholate, lithocholylglycine, and their respective 3alpha-sulfates was defined in healthy subjects. Binding of these bile acids to serum protein in vitro was measured by ultrafiltration. Lithocholate and lithocholylglycine rapidly disappeared from plasma (t1/2 less than 3 min), showing a behavior similar to that of the other major primary bile acids present in man. However, after 15 min, when 99% of the radioactivity had been cleared, the disappearance curve flattened, and chromatography suggested that the chemical form of circulating radioactivity had become sulfolithocholylglycine, the end product of hepatic metabolism of lithocholate in man. Injected sulfolithocholate and sulfolithocholylglycine were cleared about one-fourth as rapidly. Lithocholate and its derivatives were tightly bound to serum proteins (87 to 99%); for a given steroid moiety and mode of conjugation, binding was altered slightly by sulfation, but all sulfated derivatives were tightly bound (greater than 95%) to serum protein. The results indicate that lithocholate, which enters the plasma compartment, whether unconjugated, conjugated, or conjugated and sulfated, will be protein-bound but nonetheless will be rapidly cleared from plasma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1150037

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

1.  Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts.

Authors:  Matthew D Krasowski; Kazuto Yasuda; Lee R Hagey; Erin G Schuetz
Journal:  Mol Endocrinol       Date:  2005-02-17

Review 2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

3.  [Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones (author's transl)].

Authors:  H Fromm; H C Erbler; A Eschler; F W Schmidt
Journal:  Klin Wochenschr       Date:  1976-12-01

4.  Altered bile acid metabolism in primary biliary cirrhosis.

Authors:  R Raedsch; B H Lauterburg; A F Hofmann
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

5.  Sulphated bile acids in duodenal juice of healthy infants and children compared with sulphated bile acids in paediatric patients with various gastroenterological diseases.

Authors:  K H Niessen; M Teufel; G Brügmann
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.

Authors:  M Takahashi; T Konishi; Y Maeda; Y Matsugu; F Akazawa; T Eto; M Okajima; K Uchida; Y Masaoka; K Okada
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

7.  Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones.

Authors:  J W Marks; S O Sue; B J Pearlman; G G Bonorris; P Varady; J M Lachin; L J Schoenfield
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

Review 8.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

9.  Influence of human serum albumin on the bile acid-mediated inhibition of liver microsomal type 1 11β-hydroxysteroid dehydrogenase.

Authors:  Yorio Maeda; Mayumi Funagayama; Akio Shinohara; Chihiro Koshimoto; Hidemi Furusawa; Hiroshi Nakahara; Yukiko Yamaguchi; Tomokazu Saitoh; Takashi Yamamoto; Kansei Komaki
Journal:  J Physiol Biochem       Date:  2014-08-10       Impact factor: 4.158

10.  Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey.

Authors:  F Bazzoli; A Roda; H Fromm; R P Sarva; E Roda; L Barbara
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.